Resistance to cancer immunotherapy in metastatic renal cell carcinoma

The prognosis of metastatic clear cell renal cell carcinoma (mccRCC) has changed dramatically over the years with the emergence of immune checkpoint inhibitors (ICI) used alone, or in combination with another ICI, or with vascular endothelial growth factor receptor tyrosine kinase inhibitor. Althoug...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreira, Marco, Pobel, Cedric, Epaillard, Nicolas, Simonaggio, Audrey, Oudard, Stéphane, Vano, Yann-Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992500/
https://www.ncbi.nlm.nih.gov/pubmed/35582435
http://dx.doi.org/10.20517/cdr.2020.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992500/
https://www.ncbi.nlm.nih.gov/pubmed/35582435
http://dx.doi.org/10.20517/cdr.2020.16

Ejemplares similares